Mechanistic description
Selective enhancement of ST3GAL5 (GM3 synthase) activity to restore optimal GM1/GM3 ratios and prevent amyloid nucleation at lipid rafts. This approach would reduce pathological GM1 accumulation that serves as a seed for Aβ fibril formation while maintaining essential ganglioside functions.
Debate provenance: derived from debate sess_SDA-2026-04-04-frontier-lipidomics-dcdbc360 on question: How do alterations in brain lipid metabolism—including gangliosides, phospholipids, cholesterol transport, and sphingolipids—contribute to amyloidogenesis, tau pathology, and synaptic dysfunction in Alzheimer disease? Examine: (1) APOE-lipid particle composition and functional consequences, (2) gang. Consensus signal: domain_expert, synthesizer, theorist discussed the mechanism terms GM1, GM1/GM3, GM3, Ganglioside, Modulation, Rebalancing, ST3GAL5, modulation. Novelty signal: synthesizer-consensus.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Ganglioside Rebalancing Therapy via ST3GAL5 Modulation. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-95c109a91f74
@misc{scidex_hypothesis_hdebate9,
title = {Ganglioside Rebalancing Therapy via ST3GAL5 Modulation},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-95c109a91f74},
note = {SciDEX artifact hypothesis:h-debate-95c109a91f74}
}